The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Paxlovid is indicated for the treatment of COVID-19 in patients with 18 years of age and older who do not require supplemental oxygen and who are at high risk for progression to severe COVID-19 (see Dosage & Administration and Pharmacology: Pharmacodynamics under Actions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
